TransCode Therapeutics, Inc. , ("TransCode" or the "Company"), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its ...
RNAi -- functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking ...
News-Medical.Net on MSN2h
C. diff uses toxic compound to gain competitive advantage in the gutThe pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills ...
The pathogen C. diff—the most common cause of health care-associated infectious diarrhea—can use a compound that kills the ...
Prominently featured in The Inner Circle, Rachel Elizabeth NeMoyer, MD, MPH is acknowledged as a Pinnacle Lifetime Member for her contributions to Advancing Thoracic Surgery with Compassion and ...
(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...
The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of ...
A scientific technique that rapidly increases the body's production of anti-inflammatory cells promoted healing from heart attacks in mice, according ...
SYDNEY, March 25 (Xinhua) -- Australia's Queensland unveiled the finalized venue plan for the 2032 Brisbane Olympic and Paralympic Games on Tuesday, following approval from the state cabinet late ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback